Search Results - "VAN REES, Bas P"

No outcome disparities in patients with diffuse large B-cell lymphoma and a low socioeconomic status by Boslooper, Karin, Hoogendoorn, Mels, van Roon, Eric N, Kibbelaar, Robby E, Storm, Huib, Hovenga, Sjoerd, Woolthuis, Gerhard, van Rees, Bas P, Klijs, Bart, Veeger, Nic J.G.M, Kluin-Nelemans, Hanneke C, de Bock, Geertruida H

“…Highlights • Low socioeconomic status (SES) did not result in disparities in standard treatment of DLBCL. • Across the SES groups an equal proportion could…”
Get full text

Do Collision tumors of the gastroesophageal junction exist? A molecular analysis by MILNE, Anya N. A, CARVALHO, Ralph, VAN REES, Bas P, VAN LANSCHOT, Jan J. B, OFFERHAUS, G. Johan A, WETERMAN, Marian A. J

“…Collision tumors are thought to arise from the accidental meeting of two independent tumors. Here we present five gastroesophageal junction tumors consisting…”
Get full text

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial by Chamuleau, Martine E.D., Burggraaff, Coreline N., Nijland, Marcel, Bakunina, Katerina, Mous, Rogier, Lugtenburg, Pieternella J., Dierickx, Daan, van Imhoff, Gustaaf W., Vermaat, Joost S.P., A.F.Marijt, Eric, Visser, Otto, Mandigers, Caroline, Bilgin, Yavuz M., Beeker, Aart, Durian, Mark F., van Rees, Bas P., Bohmer, Lara H., Tick, Lidwine W., Boersma, Rinske S., Snijders, Tjeerd J.F., Schouten, Harry C., Koene, Harry R., de Jongh, Eva, Hijmering, Nathalie, Diepstra, Arjan, van de Berg, Anke, Arens, Anne I.J., Huijbregts, Julia, Hoekstra, Otto, Zijlstra, Josee M., de Jong, Daphne, Kersten, Marie José

“…Patients with MYC -rearrangement positive large B-cell lymphoma ( MYC + LBCL) have an inferior prognosis following standard first-line therapy with rituximab,…”
Get full text

Overall Survival Patterns in Patients with Multiple Myeloma in the Era of Novel Agents and the Role of Initial Clinical Presentation and Comorbidities: A Population-Based Study by Oortgiesen, Berdien, Roon, Eric N. van, Joosten, Peter, Kibbelaar, Robby, Storm, Huib, Hovenga, Sjoerd, Van Rees, Bas P, Woolthuis, Gerhard, Veeger, Nic J.G.M., Hoogendoorn, Mels

“…Introduction Clinical trials have shown improved response rates, progression-free survival and overall survival (OS) in patients with multiple myeloma (MM)…”
Get full text